17.07.2014 • News

Luciano Rossetti Moves from Merck to Merck

Merck Serono, the biopharmaceutical division of Germany's Merck KGaA has appointed Luciano Rossetti as executive vice president and global head of research & development with effect from July 2.

Rossetti most recently was Senior Vice President Late Stage Development at US pharmaceutical producer Merck Sharp & Dohme, where he was responsible for the entire clinical development from Phase II to Phase V across all therapeutic areas.

The new R&D chief will be based in Billerica, outside Boston, Massachusetts, in the US, one of Merck Serono's four global R&D hubs, and will share his time between Merck's headquarters in Darmstadt, Germany, and Billerica.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Top-Feature

most read